Yale spinout, the New Haven Bexorg, has built a machine that keeps a donated human brain biologically functional outside the body for up to a day. The brains aren't conscious or "alive" in any philosophical sense, but their cells are still metabolizing, still responding to drugs and therapies in ways that matter. Why does this matter? Brain drug trials currently fail 95–99% of the time, largely because we test on rodents instead of real human tissue. Bexorg gives researchers an earlier, better testing ground — potentially saving billions of dollars and years of wasted development. Read the full story to see how it works — and why it could accelerate cures for Alzheimer's and Parkinson's that millions of people are waiting for.